1. Home
  2. EVOK vs GITS Comparison

EVOK vs GITS Comparison

Compare EVOK & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • GITS
  • Stock Information
  • Founded
  • EVOK 2007
  • GITS 2018
  • Country
  • EVOK United States
  • GITS South Korea
  • Employees
  • EVOK N/A
  • GITS N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • GITS
  • Sector
  • EVOK Health Care
  • GITS
  • Exchange
  • EVOK Nasdaq
  • GITS Nasdaq
  • Market Cap
  • EVOK 4.2M
  • GITS 4.8M
  • IPO Year
  • EVOK 2013
  • GITS N/A
  • Fundamental
  • Price
  • EVOK $2.59
  • GITS $1.17
  • Analyst Decision
  • EVOK
  • GITS
  • Analyst Count
  • EVOK 0
  • GITS 0
  • Target Price
  • EVOK N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • EVOK 16.5K
  • GITS 86.4K
  • Earning Date
  • EVOK 05-13-2025
  • GITS 11-20-2024
  • Dividend Yield
  • EVOK N/A
  • GITS N/A
  • EPS Growth
  • EVOK N/A
  • GITS N/A
  • EPS
  • EVOK N/A
  • GITS N/A
  • Revenue
  • EVOK $10,249,415.00
  • GITS N/A
  • Revenue This Year
  • EVOK $58.84
  • GITS N/A
  • Revenue Next Year
  • EVOK $58.11
  • GITS N/A
  • P/E Ratio
  • EVOK N/A
  • GITS N/A
  • Revenue Growth
  • EVOK 97.84
  • GITS 85.47
  • 52 Week Low
  • EVOK $1.94
  • GITS $0.10
  • 52 Week High
  • EVOK $12.32
  • GITS $5.06
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 47.70
  • GITS N/A
  • Support Level
  • EVOK $2.02
  • GITS N/A
  • Resistance Level
  • EVOK $2.53
  • GITS N/A
  • Average True Range (ATR)
  • EVOK 0.22
  • GITS 0.00
  • MACD
  • EVOK 0.10
  • GITS 0.00
  • Stochastic Oscillator
  • EVOK 97.01
  • GITS 0.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: